Transient elastography using Fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease

European Journal of Gastroenterology and Hepatology

Volumn 27, Issue 9, 2015, Pages 1074-1079

  Fernandez, Michael ^a   Trépo, Eric ^a   Degré, Delphine ^a   Gustot, Thierry ^a   Verset, Laurine ^b   Demetter, Pieter ^b   Devière, Jacques ^a   Adler, Michael ^a   Moreno, Christophe ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

alcoholic liver disease; alcoholic steatohepatitis; aspartate aminotransferase; cirrhosis; Fibroscan; fibrosis; liver biopsy; METAVIR; transient elastography

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BIOCHEMICAL MARKER; BIOLOGICAL MARKER;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIGESTIVE SYSTEM DISEASE ASSESSMENT; DISEASE CLASSIFICATION; DISEASE SEVERITY; ELASTOGRAPH; ELASTOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION TEST KIT; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RIGIDITY; SCORING SYSTEM; THROMBOCYTE COUNT; BELGIUM; BIOPSY; BLOOD; ECHOGRAPHY; ENZYME ASSAY; ENZYMOLOGY; EVALUATION STUDY; LIVER; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX;

ASPARTATE AMINOTRANSFERASES; BELGIUM; BIOMARKERS; BIOPSY; CLINICAL ENZYME TESTS; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MIDDLE AGED; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84938941614     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000392     Document Type: Article

References (37)

1. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009; 373: 2223-2233
2. World Health Organization (WHO) (2014). Global status report on alcohol and health 2011. Switzerland: World Health Organization (WHO
3. MacSween RN, Burt AD. Histological spectrum of alcoholic liver disease. Semin Liver Dis 1986; 6: 221-232
4. Ho AM, Contardi LH, Ho AM, Contardi LH, Teli MR, Day CP, et al. Pure alcoholic fatty liver and progression to cirrhosis or fibrosis. Lancet 1995; 346: 1562-1563
5. Naveau S, Raynard B, Ratziu V, Abella A, Imbert-Bismut F, Messous D, et al. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease. Clin Gastroenterol Hepatol 2005; 3: 167-174
6. Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011; 141: 1572-1585
7. Becker U, Deis A, Sørensen TI, Grønbaek M, Borch-Johnsen K, Müller CF, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996; 23: 1025-1029
8. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000; 32: 477-481
9. Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-1457
10. Bedossa P, Poynard T, Naveau S, Martin ED, Agostini H, Chaput JC. Observer variation in assessment of liver biopsies of alcoholic liver disease in drinkers. Gastroenterology 1991; 100: 1397-1402
11. Poynard T, Ratziu V, Bedossa P. Appropriateness of liver biopsies. Can J Gastroenterol 2000; 14: 543-548
12. Gordon H. Detection of alcoholic liver disease. World J Gastroenterol 2001; 7: 297-302
13. Tran A, Hastier P, Barjoan EM, Demuth N, Pradier C, Saint-Paul MC, et al. Non invasive prediction of severe fibrosis in patients with alcoholic liver disease. Gastroenterol Clin Biol 2000; 24: 626-630
14. Lieber CS, Weiss DG, Morgan TR, Paronetto F. Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis. Am J Gastroenterol 2006; 101: 1500-1508
15. Forns X, Ampurdanès S, Llovet JM, Aponte J, Quintó L, Martínez-Bauer E, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002; 36 (4 Pt 1): 986-992
16. Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 2007; 46: 32-36
17. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. MULTIVIRC Group. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069-1075
18. Halfon P, Imbert-Bismut F, Messous D, Antoniotti G, Benchetrit D, Cart-Lamy P, et al A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease. Comp Hepatol 2002; 1: 3
19. Naveau S, Gaudé G, Asnacios A, Agostini H, Abella A, Barri-Ova N, et al. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology 2009; 49: 97-105
20. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-1713
21. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54
22. Castéra L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI and liver biopsy for the assessment of fibrosis in chronic hepatits C. Gastroenterology 2005; 128: 343-350
23. Ganne-Carrié N, Ziol M, de Ledinghen V, Douvin C, Marcellin P, Castera L, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006; 44: 1511-1517
24. Mueller S, Millonig G, Sarovska L, Friedrich S, Reimann FM, Pritsch M, et al. Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J Gastroenterol 2010; 16: 966-972
25. Nahon P, Kettaneh A, Tengher-Barna I, Ziol M, de Lédinghen V, Douvin C, et al. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J Hepatol 2008; 49: 1062-1068
26. Nguyen-Khac E, Chatelain D, Tramier B, Decrombecque C, Robert B, Joly JP, et al. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven noninvasive laboratory tests. Aliment Pharmacol Ther 2008; 28: 1188-1198
27. Janssens F, de Suray N, Piessevaux H, Horsmans Y, de Timary P, Stärkel P. Can transient elastography replace liver histology for determination of advanced fibrosis in alcoholic patients: a real-life study. J Clin Gastroenterol 2010; 44: 575-582
28. Kim SG, Kim YS, Jung SW, Kim HK, Jang JY, Moon JH, et al the usefulness of transient elastography to diagnose cirrhosis in patients with alcoholic liver disease. Korean J Hepatol 2009; 15: 42-51
29. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatits C the Metavir Cooperative Study Group. Hepatology 1996; 24: 289-293
30. Michalak S, Rousselet MC, Bedossa P, Pilette C, Chappard D, Oberti F, et al. Respective role of porto-septal fibrosis and centrilobular fibrosis in alcoholic liver disease. J Pathol 2003; 201: 55-62
31. Poynard T, Mathurin P, Lai CL, Guyader D, Poupon R, Tainturier MH, et al A comparison of fibrosis progression in chronic liver diseases. J Hepatol 2003; 38: 257-265
32. Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 75: 193-199
33. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-526
34. European Association for the Study of the Liver-European Organisation for Research and Treatment of Cancer (EASL-EORTC). Clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-943
35. Poynard T, Morra R, Halfon P, Castera L, Ratziu V, Imbert-Bismut F, et al. Meta-Analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterol 2007; 7: 40
36. Burt AD, MacSween RN. Hepatic vein lesions in alcoholic liver disease: retrospective biopsy and necropsy study. J Clin Pathol 1986; 39: 63-67
37. Trabut JB, Thépot V, Nalpas B, Lavielle B, Cosconea S, Corouge M, et al. Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers. Alcohol Clin Exp Res 2012; 36: 1407-1411